Eckert & Ziegler BEBIG, Mick Radio-Nuclear Instruments, WOLF-Medizintechnik (WOmed)


Wir halten Sie auf dem Laufenden! Wenn Sie Fragen zu unseren Pressemitteilungen haben, können Sie uns gerne über das Kontaktformular der Website kontaktieren. Bleiben Sie über die neuesten Nachrichten unseres Unternehmens auf dem Laufenden:

Eckert & Ziegler BEBIG installs first MultiSource® afterloader in Myanmar

Seneffe, Belgium, August 26, 2015, Eckert & Ziegler BEBIG installed the first MultiSource® afterloader in Myanmar. The installation was done in the Mandalay General Hospital and is the first HDR afterloader in the country using cobalt-60.

The Radiotherapy Department of the Mandalay General Hospital has worked with manual brachytherapy in recent years and now started with HDR afterloading for gynecological cancers. The first treatments were already performed at the end of July after intense training sessions with Eckert & Ziegler BEBIG application specialists. Antonius Spiller, Senior Application Specialist with a record in radiation therapy of more than 25 years states: "Myanmar has an aspiring healthcare sector and healthcare professionals are eager to incorporate efficient and cost-effective equipment in the fight against cancer." In the Mandalay General Hospital, MultiSource® will have a significant impact on the treatment of cervical cancer which is the second most frequent cancer among women in the Southeast Asian country. Every year 5286 women are diagnosed with cervical cancer and 2998 die from the disease.

"Our training, which accompanied the installation of the Co-60 machine, included a complete range of tasks from the HDR brachytherapy process like source quality insurance, security and emergency procedures, use of applicators, software training on the treatment planning system HDRplusTM, set-up and testing of DICOM settings at the C-arm and CT. Application specialists were also present during the first treatments for assistance if necessary." explains Antonius Spiller.

Eckert & Ziegler BEBIG has a dedicated team of application specialists around the world who support customers from the installation to the end of life of our products. Our goal is to assist in all steps of the brachytherapy treatment process to ensure optimal system use. For more information, please contact your local Eckert & Ziegler BEBIG representative or write an e-mail to

About Eckert & Ziegler BEBIG

Contributing to saving lives!

Eckert & Ziegler BEBIG is a European-based group active in the medical device segment of the health care industry. Its core business is the production and distribution of medical products for the treat­ment of cancer using brachytherapy. The company headquarters are in Belgium, with production facilities in Germany and in the USA, as well as subsidiaries throughout Europe, the USA, India and Brazil. In addition, Eckert & Ziegler BEBIG has a worldwide network of distributors and agents, to support the international marketing and distribution of its product line. The company's products and equipment are intended for use by oncologists, radiotherapists, urologists, ophthalmologists and medical physicists.
Eckert & Ziegler BEBIG employs approximately 200 people. The company has been listed on the Euronext stock exchange since April 1997.

Annica Witt
Marketing Communication Manager